WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Satsuma Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-10-09 1:53 pm Sale |
2020-09-30 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-1,343,168 (Position Closed) |
Filing |
| 2020-08-10 09:43 am Sale |
2020-07-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
WELLINGTON MANAGEMENT CO LLP | 1,343,168 7.720% |
-998,043 (-42.63%) |
Filing |